Bronchodilators use decreased in bronchiolitis in infants, abiding by AAP recommendations
Massachusetts: The use of bronchodilators decreased significantly from 2010 to 2018 for treatment of infants with bronchiolitis, reveals findings from a large study of infants at children's hospitals.
The study, published in the journal Pediatrics, supports the current recommendation of the American Academy of Pediatrics to limit routine use of bronchodilators for the treatment of infants with bronchiolitis.
Kristen H. Shanahan, Harvard University, Boston, Massachusetts, and colleagues aimed to characterize trends in and outcomes associated with the use of bronchodilators for bronchiolitis in a multicenter retrospective study of infants <12 months of age with bronchiolitis from 49 children's hospitals from 2010 to 2018.
The primary outcomes were rates of hospital admissions, ICU admissions, emergency department (ED) return visits after initial ED discharge, noninvasive ventilation, and invasive ventilation. The researchers used multivariable logistic regression to evaluate the rates of outcomes among hospitals with high and low early use of bronchodilators (on day of presentation).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.